Enanta Pharmaceuticals
ENTA
#7808
Rank
NZ$0.38 B
Marketcap
$17.99
Share price
-1.93%
Change (1 day)
29.60%
Change (1 year)

P/S ratio for Enanta Pharmaceuticals (ENTA)

P/S ratio as of November 2024 (TTM): 3.14

According to Enanta Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.52. At the end of 2024 the company had a P/S ratio of 3.82.

P/S ratio history for Enanta Pharmaceuticals from 2013 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20243.8241.82%
20232.69-77.16%
202211.8-28.54%
202116.598.3%
20208.3227.67%
20196.5112.81%
20185.77-32.86%
20178.60-32.26%
201612.7169.68%
20154.71-38.15%
20147.61-92.1%
201396.3

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
5.50 75.13%๐Ÿ‡บ๐Ÿ‡ธ USA
4.19 33.51%๐Ÿ‡บ๐Ÿ‡ธ USA
12.2 288.91%๐Ÿ‡บ๐Ÿ‡ธ USA
3.99 27.16%๐Ÿ‡บ๐Ÿ‡ธ USA
2.52-19.60%๐Ÿ‡บ๐Ÿ‡ธ USA
4.20 33.82%๐Ÿ‡จ๐Ÿ‡ญ Switzerland